U. of Chicago Booth School Presents Distinguished Alumni Award to Amy Ellis
Prestigious Award Recognizes Outstanding Professional Achievement
Hamilton, NJ (May 2, 2017) — MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that Amy Ellis, president and co-founder, has been selected to receive the Distinguished Alumni Award (DAA) from the University of Chicago Booth School of Business.
Ellis will be presented with the 2017 Entrepreneurial Award at a banquet later this week, honoring career-long achievements of the highest caliber as an entrepreneur, launching global innovations and managing a growing enterprise. The Chicago Booth DAA, established in 1971, recognizes outstanding accomplishments that embody the school’s dedication to limitless inquiry and courageous leadership among its more than 51,000 alumni.
In making its announcement, the selection committee said, “Amy Fershko Ellis, ’80, president and co-founder of MedAvante, Inc., is a disruptive innovator who has developed her novel ideas into successful products spanning more than 21 consumer, business, and healthcare categories. She spearheaded the development of MedAvante’s groundbreaking methodological and technological innovations, including the centralization of drug efficacy trial ratings and the Virgil® eSource Platform to change the way human drug trials are conducted.”
Paul M. Gilbert, MedAvante CEO and co-founder, said, “All of Amy’s colleagues are proud that the Booth School has confirmed what we have all known for a very long time – that she is an outstanding role model for entrepreneurs and a creative force who turns pioneering ideas into profitable marketplace realities.”
“Amy brings systematic thinking to the task of leading innovation, one of the most perilous decision-making environments,” said Gilbert. “Her ability to cut through to the core issue with incisive questioning, probing and proving, combined with deep business acumen, has enabled her to achieve an admirable track record of significant innovations.”
“We are all especially gratified that the Chicago Booth Distinguished Alumni Award recognizes Amy’s accomplishments in developing MedAvante’s unique company culture and mission,” said Gilbert. “We have worked together for years to build an environment in which all employees feel their voices are heard and their contributions are meaningful and essential.”
Previous recipients of the Chicago Booth DAA Entrepreneurial Award include Daniel P. Caruso, CEO of Zayo Group, Matthew M. Maloney, cofounder of GrubHub, Dhiraj Rajaram, founder of MuSigma, and David G. Booth, co-founder of Dimensional Fund Advisors.
MedAvante is the global clinical data services company dedicated to maximizing signal detection in clinical trials. Founded in 2002, MedAvante pioneered Central Ratings, a groundbreaking clinical trial methodology. This heritage of clinical expertise, coupled with technical innovation and operational skills, enabled MedAvante to develop the electronic source (eSource) platform, Virgil, the first such technology to replace costly and error-prone paper rating scales with real-time digital collection and cloud management of source data. Designed by clinicians for clinicians, Virgil offers built-in clinical guidance to ensure accurate, standardized assessments. MedAvante helps brings better drug therapies to market through smarter, faster clinical trials. Based in Hamilton, NJ with operations teams in the US, Germany, Russia and Japan, MedAvante delivers services for clinical trials in more than 40 countries worldwide. For more information, please visit www.medavante.com.